acetaminophen 250 MG
RxNorm concept 315259, clinical drug component (scdc).
- RxCUI
- 315259
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/315259 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin] (SBD, constitutes)
- acetaminophen 250 MG / caffeine 50 MG / magnesium salicylate 290 MG Oral Tablet (SCD, constitutes)
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet (SCD, constitutes)
- acetaminophen 250 MG / magnesium salicylate 250 MG / pamabrom 25 MG Oral Tablet (SCD, constitutes)
- acetaminophen 250 MG / caffeine 32.5 MG / magnesium salicylate 310 MG Oral Tablet (SCD, constitutes)
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Anacin Advanced Headache Formula] (SBD, constitutes)
- acetaminophen 250 MG / caffeine 50 MG / magnesium salicylate 290 MG Oral Tablet [Backprin] (SBD, constitutes)
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Pamprin Max Formula] (SBD, constitutes)
- acetaminophen 250 MG / magnesium salicylate 250 MG / pamabrom 25 MG Oral Tablet [Pamprin Cramp Formula] (SBD, constitutes)
- acetaminophen 250 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule (SCD, constitutes)
- acetaminophen 250 MG / dextromethorphan hydrobromide 10 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule (SCD, constitutes)
- acetaminophen 250 MG / doxylamine succinate 25 MG / salicylamide 150 MG Oral Tablet (SCD, constitutes)
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Arthriten Inflammatory Pain] (SBD, constitutes)
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Backaid IPF] (SBD, constitutes)
- acetaminophen 250 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule (SCD, constitutes)
- acetaminophen 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Effervescent Oral Tablet (SCD, constitutes)
- acetaminophen 250 MG / phenylephrine hydrochloride 5 MG Effervescent Oral Tablet (SCD, constitutes)
- acetaminophen 250 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Effervescent Oral Tablet (SCD, constitutes)
- acetaminophen 250 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Effervescent Oral Tablet (SCD, constitutes)
- acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG Oral Tablet (SCD, constitutes)
- acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG Oral Tablet [Excedrin PM Triple Action] (SBD, constitutes)
- acetaminophen 250 MG / ibuprofen 125 MG Oral Tablet (SCD, constitutes)
- acetaminophen (IN, has ingredient)
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Excedrin] (SBDC, has tradename)
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Anacin Advanced Headache Formula] (SBDC, has tradename)
- acetaminophen 250 MG / caffeine 50 MG / magnesium salicylate 290 MG [Backprin] (SBDC, has tradename)
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Pamprin Max Formula] (SBDC, has tradename)
- acetaminophen 250 MG / magnesium salicylate 250 MG / pamabrom 25 MG [Pamprin Cramp Formula] (SBDC, has tradename)
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Arthriten Inflammatory Pain] (SBDC, has tradename)
- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Backaid IPF] (SBDC, has tradename)
- acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG [Excedrin PM Triple Action] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 315259 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/315259 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 315259. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.